51. Acute management of cerebral venous thrombosis: Indications, technique, and outcome of endovascular treatment in two high-volume centers
- Author
-
Sousa, João André, Achutegui, Maider Iza, Juega-Mariño, Jesus, Requena, Manuel, Bernardo-Castro, Sara, Rodrigo-Gisbert, Marc, Rizzo, Federica, Olivé, Marta, Garcia-Tornel, Álvaro, Chaves, Ana Carolina, Rodriguez-Villatoro, Noelia, Muchada, Marian, Pagola, Jorge, Rodriguez-Luna, David, Rubiera, Marta, Martins, Ana Inês, Silva, Fernando, Veiga, Ricardo, Nunes, Cesar, Machado, Egídio, Diana, Francesco, de Dios, Marta, Hernández, David, Ribo, Marc, Molina, Carlos, Sargento-Freitas, João, and Tomasello, Alejandro
- Abstract
Introduction After several uncontrolled studies and one randomized clinical trial, there is still uncertainty regarding the role of endovascular treatment (EVT) in cerebral venous thrombosis (CVT). This study aims to describe and assess different acute management strategies in the treatment of CVT.Methods We performed a retrospective analysis of an international two-center registry of CVT patients admitted since 2019. Good outcome was defined as a return to baseline modified Rankin scale at three months. We described and compared EVT versus no-EVT patients.Results We included 61 patients. Only one did not receive systemic anticoagulation. EVT was performed in 13/61 (20%) of the cases, with a median time from diagnosis to puncture of 4.5 h (1.25–28.5). EVT patients had a higher median baseline NIHSS [6 (IQR 2–17) vs 0 (0–2.7), p= 0.002)] and a higher incidence of intracerebral hemorrhage (53.8% vs 20.3%, p= 0.03). Recanalization was achieved in 10/13 (77%) patients. Thrombectomy was performed in every case with angioplasty in 7 out of 12 patients and stenting in 3 cases. No postprocedural complication was reported. An improvement of the median NIHSS from baseline to discharge [6 (2–17) vs 1(0–3.75); p< 0.001] was observed in EVT group. A total of 31/60 patients (50.8%) had good outcomes. Adjusting to NIHSS and ICH, EVT had a non-significant increase in the odds of a good outcome [aOR 1.42 (95%CI 0.73–2.8, p= 0.307)].Conclusions EVT in combination with anticoagulation was safe in acute treatment of CVT as suggested by NIHSS improvement. Selected patients may benefit from this treatment.
- Published
- 2024
- Full Text
- View/download PDF